Effect of conformation on the photodegradation of Trp- and cystine-containing cyclic peptides: Octreotide and somatostatin

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3537-3546

  Mozziconacci, Olivier ^a   Schöneich, Christian ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

3 methyleneindolenine; disulfide; octreotide; photochemistry; somatostatin; stability; tryptophan

Indexed keywords

CARBONYL DERIVATIVE; CYCLOPEPTIDE; CYSTINE; HADACIDIN; OCTREOTIDE; OXYGEN; SOMATOSTATIN; 3-METHYLENEINDOLENINE; INDOLE DERIVATIVE; TRYPTOPHAN;

ARTICLE; DISULFIDE BOND; FLUORESCENT LIGHTING; IRRADIATION; PHOTODEGRADATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; PHOTOCHEMISTRY; PROCEDURES; STRUCTURE ACTIVITY RELATION;

CYSTINE; INDOLES; MOLECULAR STRUCTURE; OCTREOTIDE; PEPTIDES, CYCLIC; PHOTOCHEMISTRY; SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTOPHAN;

EID: 84908006894     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5003174     Document Type: Article

References (83)

1. Merrifield, R. B. Solid Phase Peptide Synthesis. I. the Synthesis of a Tetrapeptide J. Am. Chem. Soc. 1963, 2149-2154
2. Fyda, D. M.; Mathieson, W. B.; Cooper, K. E.; Veale, W. L. The Effectiveness of Arginine Vasopressin and Sodium Salicylate as Antipyretics in the Brattleboro Rat Brain Res. 1990, 512, 243-247
3. Murali, S.; Uretsky, B. F.; Valdes, A. M.; Kolesar, J. A.; Reddy, P. S. Acute Hemodynamic and Hormonal Effects of CI-930, a New Phosphodiesterase Inhibitor, in Severe Congestive Heart Failure Am. J. Cardiol. 1987, 59, 1356-1360
4. Beaulieu, M. J. Vasopressin for the Treatment of Neonatal Hypotension Neonatal Network 2013, 32, 120-124
5. Manning, M.; Olma, A.; Klis, W. A.; Kolodziejczyk, A. M.; Seto, J.; Sawyer, W. H. Design of More Potent Antagonists of the Antidiuretic Responses to Arginine-Vasopressin J. Med. Chem. 1982, 25, 45-50
6. Becker, D. J.; Foley, T. P. 1-Deamino-8- d -Arginine Vasopressin in the Treatment of Central Diabetes Insipidus in Childhood J. Pediatr. 1978, 92, 1011-1015
7. Bora, E.; Yucel, M.; Allen, N. B. Neurobiology of Human Affiliative Behaviour: Implications for Psychiatric Disorders Curr. Opin. Psychiatry 2009, 22, 320-325
8. Alizadeh, A. M.; Mirzabeglo, P. Is Oxytocin a Therapeutic Factor for Ischemic Heart Disease? Peptides 2013, 45, 66-72
9. Shyken, J. M.; Petrie, R. H. Oxytocin to Induce Labor Clin. Obstet. Gynecol. 1995, 38, 232-245
10. Strunecka, A.; Hynie, S.; Klenerova, V. Role of Oxytocin/Oxytocin Receptor System in Regulation of Cell Growth and Neoplastic Processes Folia Biol. (Praha) 2009, 55, 159-165
11. Williams, P. D.; Bock, M. G.; Evans, B. E.; Freidinger, R. M.; Pettibone, D. J. Progress in the Development of Oxytocin Antagonists for Use in Preterm Labor Adv. Exp. Med. Biol. 1998, 449, 473-479
12. Cutler, G. B.; Hoffman, A. R.; Swerdloff, R. S.; Santen, R. J.; Meldrum, D. R.; Comite, F. NIH Conference. Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its Analogs Ann. Int. Med. 1985, 102, 643-657
13. Bowen, R. L.; Verdile, G.; Liu, T.; Parlow, A. F.; Perry, G.; Smith, M. A.; Martins, R. N.; Atwood, C. S. Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-Beta Precursor Protein and Amyloid-Beta Deposition J. Biol. Chem. 2004, 279, 20539-20545
14. Moreau, J.-P.; Delavault, P.; Blumberg, J. Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Prostate Cancer: a Review of Their Discovery, Development, and Place in Therapy Clin. Ther. 2006, 28, 1485-1508
15. Curtis, G. C.; Abelson, J. L.; Gold, P. W. Adrenocorticotropic Hormone and Cortisol Responses to Corticotropin-Releasing Hormone: Changes in Panic Disorder and Effects of Alprazolam Treatment Biol. Psychiatry 1997, 41, 76-85
16. Arnason, B. G.; Berkovich, R.; Catania, A.; Lisak, R. P.; Zaidi, M. Mechanisms of Action of Adrenocorticotropic Hormone and Other Melanocortins Relevant to the Clinical Management of Patients with Multiple Sclerosis Mult. Scler. 2013, 19, 130-136
17. Pandit, M. K.; Burke, J.; Gustafson, A. B.; Minocha, A.; Peiris, A. N. Drug-Induced Disorders of Glucose Tolerance Ann. Int. Med. 1993, 118, 529-539
18. Gutman, A.; Yu, T. Effects of Adrenocorticotropic Hormone (Acth) in Gout Am. J. Med. 1950, 9, 24-30
19. Singer, F. R. Clinical Efficacy of Salmon Calcitonin in Pagets Disease of Bone Calcif. Tissue Int. 1991, 49 (Suppl 2) S7-S8
20. Chesnut, C. H. Review of Calcitonin-Present: Current Status of Calcitonin as a Therapeutic Agent Bone Miner. 1992, 16, 211-212
21. Chesnut, C. H.; Azria, M.; Silverman, S.; Engelhardt, M.; Olson, M.; Mindeholm, L. Salmon Calcitonin: a Review of Current and Future Therapeutic Indications Osteoporosis Int. 2008, 19, 479-491
22. Hay, J. E.; Malinchoc, M.; Dickson, E. R. A Controlled Trial of Calcitonin Therapy for the Prevention of Post-Liver Transplantation Atraumatic Fractures in Patients with Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis J. Hepatol. 2001, 34, 292-298
23. Silva, O. L.; Becker, K. L. Salmon Calcitonin in the Treatment of Hypercalcemia Arch. Int. Med. 1973, 132, 337-339
24. McDermott, M. T.; Kidd, G. S. The Role of Calcitonin in the Development and Treatment of Osteoporosis Endocr. Rev. 1987, 8, 377-390
25. Scarpignato, C.; Pelosini, I. Somatostatin Analogs for Cancer Treatment and Diagnosis: an Overview Chemotherapy 2001, 47 (Suppl 2) 1-29
26. Paran, D.; Paran, H. Somatostatin Analogs in Rheumatoid Arthritis and Other Inflammatory and Immune-Mediated Conditions Curr. Opin. Investig. Drugs 2003, 4, 578-582
27. Casini, G.; Catalani, E.; Dal Monte, M.; Bagnoli, P. Functional Aspects of the Somatostatinergic System in the Retina and the Potential Therapeutic Role of Somatostatin in Retinal Disease Histol. Histopathol. 2005, 20, 615-632
28. Tejeda, M.; Gaál, D.; Hullán, L.; Schwab, R.; Szokoloczi, O.; Kéri, G. Antitumor Activity of the Somatostatin Structural Derivative (TT-232), Against Mouse and Human Melanoma Tumor Models Anticancer Res. 2007, 27, 4015-4019
29. Grant, M. B.; Caballero, S. Somatostatin Analogues as Drug Therapies for Retinopathies Drugs Today 2002, 38, 783-791
30. Woltering, E. A. Development of Targeted Somatostatin-Based Antiangiogenic Therapy: a Review and Future Perspectives Cancer Biother. Radiopharm. 2003, 18, 601-609
31. Long, R. G.; Barnes, A. J.; Adrian, T. E.; Mallinson, C. N.; Brown, M. R.; Vale, W.; Rivier, J. E.; Christofides, N. D.; Bloom, S. R. Suppression of Pancreatic Endocrine Tumour Secretion by Long-Acting Somatostatin Analogue Lancet 1979, 2, 764-767
32. Brown, M.; Rivier, J.; Vale, W. Somatostatin Analogs with Selected Biologic Activities Metab., Clin. Exp. 1976, 25, 1501-1503
33. Rivier, J.; Brown, M.; Vale, W. d -Trp8-Somatostatin: an Analog of Somatostatin More Potent Than the Native Molecule Biochem. Biophys. Res. Commun. 1975, 65, 746-751
34. Reichlin, S. Somatostatin N. Engl. J. Med. 1983, 309, 1495-1501
35. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T. J. Pless. SMS 201-995: a Very Potent and Selective Octapeptide Analogue of Somatostatin with Prolonged Action Life Sci. 1982, 31, 1133-1140
36. Battershill, P. E.; Clissold, S. P. Octreotide. a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Conditions Associated with Excessive Peptide Secretion Drugs 1989, 38, 658-702
37. Newman, C. B.; Melmed, S.; George, A.; Torigian, D.; Duhaney, M.; Snyder, P.; Young, W.; Klibanski, A.; Molitch, M. E.; Gagel, R.; Sheeler, L.; Cook, D.; Malarkey, W.; Jackson, I.; Vance, M. L.; Barkan, A.; Frohman, L.; Kleinberg, D. L. Octreotide as Primary Therapy for Acromegaly J. Clin. Endocrinol. Metab. 1998, 83, 3034-3040
38. Gu, P.; Wu, J.; Newman, E.; Muggia, F. Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin Int. J. Hepatol. 2012, 2012, 131659-8
39. Kvols, L. K.; Oberg, K. E.; ODorisio, T. M.; Mohideen, P.; de Herder, W. W.; Arnold, R.; Hu, K.; Zhang, Y.; Hughes, G.; Anthony, L.; Wiedenmann, B. Pasireotide (SOM230) Shows Efficacy and Tolerability in the Treatment of Patients with Advanced Neuroendocrine Tumors Refractory or Resistant to Octreotide LAR: Results From a Phase II Study Endocr.-Relat. Cancer 2012, 19, 657-666
40. Di Lorenzo, C.; Lucanto, C.; Flores, A. F.; Idries, S.; Hyman, P. E. Effect of Octreotide on Gastrointestinal Motility in Children with Functional Gastrointestinal Symptoms J. Pediatr. Gastroenterol. Nutr. 1998, 27, 508-512
41. Hardt, P. D.; Kress, O.; Fadgyas, T.; Doppl, W.; Schnell-Kretschmer, H.; Wüsten, O.; Klör, H. U. Octreotide in the Prevention of Pancreatic Damage Induced by Endoscopic Sphincterotomy Eur. J. Med. Res. 2000, 5, 165-170
42. Manni, A. Somatostatin and Growth Hormone Regulation in Cancer Biotherapy 1992, 4, 31-36
43. Fielding, H.; Kyaterekera, N.; Skellern, G. G.; Tettey, J. N.; McDade, J. R.; Msuya, Z.; Watson, D. G.; Urie, J. The Compatibility and Stability of Octreotide Acetate in the Presence of Diamorphine Hydrochloride in Polypropylene Syringes Palliative Med. 2000, 14, 205-207
44. Pattison, D. I.; Rahmanto, A. S.; Davies, M. J. Photo-Oxidation of Proteins Photochem. Photobiol. Sci. 2011, 11, 38-53
45. Bent, D. V.; Hayon, E. Excited State Chemistry of Aromatic Amino Acids and Related Peptides. III. Tryptophan J. Am. Chem. Soc. 1975, 97, 2612-2619
46. Creed, D. The Photophysics and Photochemistry of the Near-UV Absorbing Amino-Acids. I. Tryptophan and Its Simple Derivatives Photochem. Photobiol. 1984, 39, 537-562
47. Grossweiner, L. I. Photochemistry of Proteins: a Review Curr. Eye Res. 1983, 3, 137-144
48. Vanhooren, A.; Devreese, B.; Vanhee, K.; Van Beeumen, J.; Hanssens, I. Photoexcitation of Tryptophan Groups Induces Reduction of Two Disulfide Bonds in Goat Alpha-Lactalbumin Biochemistry 2002, 41, 11035-11043
49. Miller, B. L.; Hageman, M. J.; Thamann, T. J.; Barròn, L. B.; Schöneich, C. Solid-State Photodegradation of Bovine Somatotropin (Bovine Growth Hormone): Evidence for Tryptophan-Mediated Photooxidation of Disulfide Bonds J. Pharm. Sci. 2003, 92, 1698-1709
50. Li, Z.; Lee, W. E.; Galley, W. C. Distance Dependence of the Tryptophan-Disulfide Interaction at the Triplet Level From Pulsed Phosphorescence Studies on a Model System Biophys. J. 1989, 361-367
51. Correia, M.; Neves-Petersen, M. T.; Parracino, A.; di Gennaro, A. K.; Petersen, S. B. Photophysics, Photochemistry and Energetics of UV Light Induced Disulphide Bridge Disruption in Apo-A-Lactalbumin J. Fluoresc. 2012, 22, 323-337
52. Neves-Petersen, M. T.; Gryczynski, Z.; Lakowicz, J.; Fojan, P.; Pedersen, S.; Petersen, E.; Bjørn Petersen, S. High Probability of Disrupting a Disulphide Bridge Mediated by an Endogenous Excited Tryptophan Residue Protein Sci. 2002, 11, 588-600
53. Pigault, C.; Gerard, D. Influence of the Location of Tryptophanyl Residues in Proteins on Their Photosensitivity Photochem. Photobiol. 1984, 40, 291-296
54. Pohl, E.; Heine, A.; Sheldrick, G. M.; Dauter, Z.; Wilson, K. S.; Kallen, J.; Huber, W.; Pfäffli, P. J. Structure of Octreotide, a Somatostatin Analogue Acta Crystallogr., Sect. D: Biol. Crystallogr. 1995, 51, 48-59
55. Haywood, J.; Mozziconacci, O.; Allegre, K. M.; Kerwin, B. A.; Schöneich, C. Light-Induced Conversion of Trp to Gly and Gly Hydroperoxide in IgG1 Mol. Pharmaceutics 2013, 10, 1146-1150
56. Ikehata, K.; Duzhak, T. G.; Galeva, N. A.; Ji, T.; Koen, Y. M.; Hanzlik, R. P. Protein Targets of Reactive Metabolites of Thiobenzamide in Rat Liver in Vivo Chem. Res. Toxicol. 2008, 21, 1432-1442
57. Umezawa, H.; Kondo, S.; Iinuma, H.; Kunimoto, S.; Ikeda, Y.; Iwasawa, H.; Ikeda, D.; Takeuchi, T. Structure of an Antitumor Antibiotic, Spergualin J. Antibiot. 1981, 34, 1622-1624
58. Sprancmanis, L. A.; Riley, C. M.; Stobaugh, J. F. Determination of the Anticancer Drug, 15-Deoxyspergualin, in Plasma Ultrafiltrate by Liquid Chromatography and Precolumn Derivatization with Naphthalene-2,3-Dicarboxaldehyde/Cyanide J. Pharm. Biomed. Anal. 1990, 8, 165-175
59. Mezyk, S. P. Rate Constant Determination for the Reaction of Sulfhydryl Species with the Hydrated Electron in Aqueous Solution J. Phys. Chem. 1995, 99, 13970-13975
60. Balkaş, T. I. The Radiolysis of Aqueous Solutions of Methylene Chloride Int. J. Radiat. Phys. Chem. 1972, 4, 199-208
61. Knappenberg, M.; Michel, A.; Scarso, A.; Brison, J.; Zanen, J.; Hallenga, K.; Deschrijver, P.; van Binst, G. The Conformational Properties of Somatostatin. IV. the Conformers Contributing to the Conformation Equilibrium of Somatostatin in Aqueous Solution as Found by Semi-Empirical Energy Calculations and High-Resolution NMR Experiments Biochim. Biophys. Acta 1982, 700, 229-246
62. Qiu, W.; Wang, L.; Lu, W.; Boechler, A.; Sanders, D. A. R.; Zhong, D. Dissection of Complex Protein Dynamics in Human Thioredoxin Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 5366-5371
63. Qiu, W.; Li, T.; Zhang, L.; Yang, Y.; Kao, Y.-T.; Wang, L.; Zhong, D. Ultrafast Quenching of Tryptophan Fluorescence in Proteins: Interresidue and Intrahelical Electron Transfer Chem. Phys. 2008, 350, 154-164
64. Qiu, W.; Zhang, L.; Okobiah, O.; Yang, Y.; Wang, L.; Zhong, D.; Zewail, A. H. Ultrafast Solvation Dynamics of Human Serum Albumin: Correlations with Conformational Transitions and Site-Selected Recognition J. Phys. Chem. B 2006, 110, 10540-10549
65. Ababou, A.; Bombarda, E. On the Involvement of Electron Transfer Reactions in the Fluorescence Decay Kinetics Heterogeneity of Proteins Protein Sci. 2001, 10, 2102-2113
66. Sillen, A.; Hennecke, J.; Roethlisberger, D.; Glockshuber, R.; Engelborghs, Y. Fluorescence Quenching in the DsbA Protein From Escherichia Coli: Complete Picture of the Excited-State Energy Pathway and Evidence for the Reshuffling Dynamics of the Microstates of Tryptophan Proteins 1999, 37, 253-263
67. Sillen, A.; Díaz, J. F.; Engelborghs, Y. A Step Toward the Prediction of the Fluorescence Lifetimes of Tryptophan Residues in Proteins Based on Structural and Spectral Data Protein Sci. 2000, 9, 158-169
68. Adams, P. D.; Chen, Y.; Ma, K.; Zagorski, M. G.; S o nnichsen, F. D.; McLaughlin, M. L.; Barkley, M. D. Intramolecular Quenching of Tryptophan Fluorescence by the Peptide Bond in Cyclic Hexapeptides J. Am. Chem. Soc. 2002, 124, 9278-9286
69. Hellings, M.; De Maeyer, M.; Verheyden, S.; Hao, Q.; Van Damme, E. J. M.; Peumans, W. J.; Engelborghs, Y. The Dead-End Elimination Method, Tryptophan Rotamers, and Fluorescence Lifetimes Biophys. J. 2003, 85, 1894-1902
70. Doktorov, A. B.; Khairutdinov, R. F.; Zamaraev, K. I. Analysis of Kinetic Models for the Tunnel Electron Transfer Reactions. Reaction Kinetics for Various Radial and Angular Dependences of the Tunneling Probability Chem. Phys. 1981, 61, 351-364
71. Domingue, R. P.; Fayer, M. D. Electron Transfer Between Molecules Randomly Distributed in a Glass J. Chem. Phys. 1985, 83, 2242-2251
72. Chen, Y.; Barkley, M. D. Toward Understanding Tryptophan Fluorescence in Proteins Biochemistry 1998, 37, 9976-9982
73. Dose, K. The Photolysis of Free Cystine in the Presence of Aromatic Amino Acids Photochem. Photobiol. 1968, 8, 331-335
74. Weisenborn, P.; Meder, H.; Egmond, M. R.; Visser, T.; vanHoek, A. Photophysics of the Single Tryptophan Residue in Fusarium Solani Cutinase: Evidence for the Occurrence of Conformational Substates with Unusual Fluorescence Behaviour Biophys. Chem. 1996, 58, 281-288
75. Prompers, J. J.; Hilbers, C. W.; Pepermans, H. Tryptophan Mediated Photoreduction of Disulfide Bond Causes Unusual Fluorescence Behaviour of Fusarium Solani Pisi Cutinase FEBS Lett. 1999, 456, 409-416
76. Permyakov, E. A.; Permyakov, S. E.; Deikus, G. Y.; Morozova-Roche, L. A.; Grishchenko, V. M.; Kalinichenko, L. P.; Uversky, V. N. Ultraviolet Illumination-Induced Reduction of Alpha-Lactalbumin Disulfide Bridges Proteins: Struct., Funct., Genet. 2003, 51, 498-503
77. Ioerger, T. R.; Du, C. G.; Linthicum, D. S. Conservation of Cys-Cys Trp Structural Triads and Their Geometry in the Protein Domains of Immunoglobulin Superfamily Members Molec. Immunol. 1999, 36, 373-386
78. Neves-Petersen, M. T.; Snabe, T.; Klitgaard, S.; Duroux, M.; Petersen, S. B. Photonic Activation of Disulfide Bridges Achieves Oriented Protein Immobilization on Biosensor Surfaces Protein Sci. 2006, 15, 343-351
79. Perez-Prieto, J.; Morant-Minana, M. C.; Galian, R. E.; Miranda, M. A. Photoreaction Between Benzoylthiophenes and N-BOC-Tryptophan Methyl Ester Photochem. Photobiol. 2006, 82, 231-236
80. Giese, B.; Eckhardt, S.; Lauz, M. Electron Transfer in Peptides and Proteins. In Encyclopedia of Radicals in Chemistry, Biology and Materials; Chatgilialoglu, C.; Studer, A., Eds.; John Wiley & Sons, Ltd: Hoboken, NJ, 2012.
81. Gay, C. A.; Gebicki, J. M. Measurement of Protein and Lipid Hydroperoxides in Biological Systems by the Ferric-Xylenol Orange Method Anal. Biochem. 2003, 29-35
82. Wasylaschuk, W. R.; Harmon, P. A.; Wagner, G.; Harman, A. B.; Templeton, A. C.; Xu, H.; Reed, R. A. Evaluation of Hydroperoxides in Common Pharmaceutical Excipients J. Pharm. Sci. 2007, 96, 106-116
83. Olsen, J. V.; Ong, S. E.; Mann, M. Trypsin Cleaves Exclusively C-Terminal to Arginine and Lysine Residues Mol. Cell Proteomics 2004, 608-614